Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CALASPARGASE PEGOL for Supportive care: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where CALASPARGASE PEGOL was used for Supportive care.

Most Reported Side Effects for CALASPARGASE PEGOL

Side Effect Reports % Deaths Hosp.
Hypertriglyceridaemia 27 21.6% 9 24
Febrile neutropenia 19 15.2% 1 17
Hypersensitivity 13 10.4% 1 6
Neutropenia 11 8.8% 1 2
Coagulopathy 10 8.0% 10 10
Hepatotoxicity 10 8.0% 10 10
Renal failure 10 8.0% 9 10
Circulatory collapse 9 7.2% 9 9
Clostridium difficile infection 9 7.2% 9 9
Electrolyte imbalance 9 7.2% 9 9
Gastrointestinal haemorrhage 9 7.2% 9 9
Hypoalbuminaemia 9 7.2% 9 9
Pancytopenia 9 7.2% 9 9
Polyneuropathy 9 7.2% 9 9
Respiratory syncytial virus infection 9 7.2% 9 9

Other Indications for CALASPARGASE PEGOL

Acute lymphocytic leukaemia (48) B-cell type acute leukaemia (32) T-cell type acute leukaemia (9)

Other Drugs Used for Supportive care

ONDANSETRON (164) DEXAMETHASONE (154) APREPITANT (132) PEGFILGRASTIM (120) FILGRASTIM (93) GRANULOCYTE COLONY-STIMULATING FACTOR NOS (36) ALLOPURINOL (34) METHOTREXATE (34) PACLITAXEL (34) DOMPERIDONE (32)

Related Pages

CALASPARGASE PEGOL Full Profile All Supportive care Drugs CALASPARGASE PEGOL Demographics CALASPARGASE PEGOL Timeline